GL Stock Recent News

Both Globe Life (GL 6.79%) executives and investors wiped their collective brows on Tuesday. The company was formally cleared in a regulatory investigation, and it was the subject of a pair of optimistic analyst updates just afterwards.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

MCKINNEY, Texas , July 28, 2025 /PRNewswire/ -- Globe Life Inc. (NYSE: GL) – Today, the U.S. Attorney's Office for the Western District of Pennsylvania notified Globe Life and American Income Life (AIL) that it has closed its investigation. Globe Life and AIL previously received and responded to subpoenas from the U.S. Attorney's Office seeking documents relating to sales practices by certain independent sales agents contracted to sell AIL policies.

Globe Life (GL -0.75%), a leading provider of life and health insurance products in the United States, released its earnings for Q2 2025 on July 23, 2025. The most significant news from the report was that adjusted earnings per share (EPS) came in at $3.27, beating the average analyst estimate of $3.25.

Insurance conglomerate Globe Life (GL 2.75%) was a safe bet of a stock on Friday, as investors snapped it up following a bullish analyst move. With that tailwind at its back, Globe Life closed the day nearly 3% higher in price, easily beating the 0.4% increase of the S&P 500 index.

MCKINNEY, Texas , July 24, 2025 /PRNewswire/ -- Globe Life Inc. (NYSE: GL) announced it received a letter today from Securities and Exchange Commission (SEC) staff notifying Globe Life that they have concluded their investigation and, based on the information gathered, do not intend to recommend an SEC enforcement action against Globe Life. About Globe Life About Globe Life: Globe Life (NYSE: GL) is headquartered in McKinney, TX, and has more than 16,000 insurance agents and 3,600 corporate employees.

Globe Life Inc. (NYSE:GL ) Q2 2025 Earnings Conference Call July 24, 2025 11:00 AM ET Company Participants Frank Martin Svoboda - Co-Chairman & Co-CEO James Matthew Darden - Co-Chairman & Co-CEO Stephen Mota - Senior Director of Investor Relations Thomas Peter Kalmbach - Executive VP & CFO Conference Call Participants Andrew Scott Kligerman - TD Cowen, Research Division Elyse Beth Greenspan - Wells Fargo Securities, LLC, Research Division Jack Matten - BMO Capital Markets Equity Research Jamminder Singh Bhullar - JPMorgan Chase & Co, Research Division John Bakewell Barnidge - Piper Sandler & Co., Research Division Mark Douglas Hughes - Truist Securities, Inc., Research Division Ryan Joel Krueger - Keefe, Bruyette, & Woods, Inc., Research Division Suneet Laxman L. Kamath - Jefferies LLC, Research Division Thomas George Gallagher - Evercore ISI Institutional Equities, Research Division Wesley Collin Carmichael - Autonomous Research US LP Wilma Carter Jackson Burdis - Raymond James & Asso

GL's Q2 earnings increase 10% as strong Life and Health premiums offset declines in investment income and rising expenses.

Globe Life (GL) came out with quarterly earnings of $3.27 per share, beating the Zacks Consensus Estimate of $3.25 per share. This compares to earnings of $2.97 per share a year ago.

Life and supplemental health insurance company Globe Life reported a rise in second-quarter profit on Wednesday, driven by stronger underwriting performance.